At the request of Sage Publishing and the Journal Editor, the following article has been retracted:
Li M, Wang Y, Zhao Q, Ma W, Liu J. MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2. Human & Experimental Toxicology. 2021;40(8):1274-1285. doi:10.1177/0960327121991913
SAGE Publishing was made aware that this article was accepted for publication as a result of compromised peer review and may have been linked to an unauthorised third party.
SAGE Publishing was made aware that this article was accepted for publication as a result of a peer review process that was compromised and contains indicators of third-party activity. The authors have explained that they undertook the research without any third-party assistance. However, the authors have been unable to provide any evidence or underlying raw data to support their authorship.
Due to concerns about the integrity of this research, the article has been retracted.
J.L. disagrees with the retraction. All other authors did not respond for comment when notified of this retraction.
References
1.
TsaoSWTsangCMLoKW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci2017; 372: 20160270.
2.
AoRFuRDongD, et al.Discerning primary tumors from metastases in synchronous nasopharyngeal squamous cell carcinoma and cutaneous squamous cell carcinoma: a case report and review of the literature. Oncol Lett2014; 7: 1391–1394.
3.
Roy ChattopadhyayNDasPChatterjeeK, et al.Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli. Drug Discov Ther2017; 11: 170–180.
4.
SunXSLiuSLLuoMJ, et al.The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012. Int J Radiat Oncol Biol Phys2019; 105: 581–590.
5.
LeeHMOkudaKSGonzálezFE, et al.Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol2019; 1164: 11–34.
6.
LiuHLeiCHeQ, et al.Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer2018; 17: 64.
7.
AcunzoMCroceCM. MicroRNA in cancer and cachexia—a mini-review. J Infect Dis2015; 212(Suppl 1): S74–77.
8.
YuYYinWYuZH, et al.miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer. J Exp Clin Cancer Res2019; 38: 22.
9.
WangSChenYYuX, et al.miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer. Pathol Res Pract2019; 215: 676–682.
10.
JinKZhaoWXieX, et al.MiR-520b restrains cell growth by targeting HDAC4 in lung cancer. Thorac Cancer2018; 9: 1249–1254.
11.
WangGWangSLiC. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma. Tumour Biol2017; 39: 1010428317703825.
12.
HeQRenXChenJ, et al.miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways. Oncotarget2016; 7: 3047–3058.
13.
ZhongQHuangJWeiJ, et al.Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma. Cancer Cell Int2019; 19: 252.
14.
WeiWYangYCaiJ, et al.MiR-30a-5p suppresses tumor metastasis of human colorectal cancer by targeting ITGB3. Cell Physiol Biochem2016; 39: 1165–1176.
15.
ZhaoHLaiXZhangW, et al.MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF. Artif Cells Nanomed Biotechnol2019; 47: 278–289.
16.
WangLZhaoSYuM. Mechanism of low expression of miR-30a-5p on epithelial-mesenchymal transition and metastasis in ovarian cancer. DNA Cell Biol2019; 38: 341–351.
17.
LeeYSDuttaA. MicroRNAs in cancer. Ann Rev Pathol2009; 4: 199–227.
18.
BruceJPLiuFF. MicroRNAs in nasopharyngeal carcinoma. Chin J Cancer2014; 33: 539–544.
19.
ShiLXiaoRWangM, et al.MicroRNA-342-3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42. Oncol Rep2018; 40: 2750–2757.
20.
JiangXDaiBFengL. miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A. Human Cell2019; 32: 477–486.
21.
ZhuHMJiangXSLiHZ, et al.miR-184 inhibits tumor invasion, migration and metastasis in nasopharyngeal carcinoma by targeting notch2. Cell Physiol Biochem2018; 49: 1564–1576.
22.
YinWShiLMaoY. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma. J Biochem2019; 166: 433–440.
23.
Di LevaGGarofaloMCroceCM. MicroRNAs in cancer. Ann Rev Pathol2014; 9: 287–314.
24.
ZhangDLinJChaoY, et al.Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression. J Exp Clin Cancer Res2018; 37: 176.
25.
HuoXWangHHuoB, et al.FTX contributes to cell proliferation and migration in lung adenocarcinoma via targeting miR-335-5p/NUCB2 axis. Cancer Cell Int2020; 20: 89.
26.
ZhaoJYunXRuanX, et al.High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion. OncoTargets Ther2019; 12: 1309–1318.
27.
XinRQuDXuH, et al.circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2. Cancer Gene Ther2020. 2020/10/29. DOI: 10.1038/s41417-020-00247-8.
